| Name | RBM5 antisense RNA 1 |
| Description | This gene produces a non-coding RNA in antisense to the RNA binding motif protein 5 (RBM5) gene. This transcript interacts with beta catenin and may regulate expression of WNT target genes. [provided by RefSeq, Sep 2016] |
| Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nLong non‐coding RNA RBM5‑AS1 is aberrantly overexpressed in several cancer types, including oral squamous cell carcinoma and osteosarcoma. In OSCC, high expression of RBM5‑AS1 has been linked to enhanced proliferation, migration, and invasion, while in osteosarcoma it is emerging as a key modulator of tumor progression."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nMechanistically, RBM5‑AS1 appears to act as an oncogenic regulator by interfacing with distinct molecular pathways. In hepatocellular carcinoma, RBM5‑AS1 recruits the polycomb repressive complex (PRC2) to elevate H3K27me3 at the promoters of tumor‐suppressive miR‑132/212, leading to their downregulation and promoting cell proliferation and invasion. In medulloblastoma, RBM5‑AS1 contributes to stemness and radioresistance through an interaction that stabilizes SIRT6 protein, thereby supporting cancer stem cell properties and survival under genotoxic stress. In breast cancer, its transcription is induced by hypoxia‐mediated RUNX2 activation and it facilitates tumorigenesis by activating the Wnt/β‑catenin pathway – stabilizing β‑catenin and promoting formation of the β‑catenin–TCF4 transcriptional complex."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "3", "end_ref": "5"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nCollectively, these studies indicate that RBM5‑AS1 functions as a multifaceted oncogenic lncRNA that modulates key signaling pathways and epigenetic regulators to foster tumor initiation, aggressive behavior, and resistance to therapy. Such findings nominate RBM5‑AS1 as a promising target for diagnostic and therapeutic intervention across a spectrum of malignancies."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "5"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Stephen R Wellard, Karen Schindler, Philip W Jordan "}, {"type": "b", "children": [{"type": "t", "text": "Aurora B and C kinases regulate chromosome desynapsis and segregation during mouse and human spermatogenesis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cell Sci (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1242/jcs.248831"}], "href": "https://doi.org/10.1242/jcs.248831"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33172986"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33172986"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Biyong Deng, Runsang Pan, Xin Ou, et al. "}, {"type": "b", "children": [{"type": "t", "text": "LncRNA RBM5-AS1 Promotes Osteosarcoma Cell Proliferation, Migration, and Invasion."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biomed Res Int (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1155/2021/5271291"}], "href": "https://doi.org/10.1155/2021/5271291"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33816613"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33816613"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Jin-Yong Mu, Jun-Xiu Tian, Ying-Jie Chen "}, {"type": "b", "children": [{"type": "t", "text": "lncRNA RBM5-AS1 promotes cell proliferation and invasion by epigenetically silencing miR-132/212 in hepatocellular carcinoma cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Biol Int (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/cbin.11649"}], "href": "https://doi.org/10.1002/cbin.11649"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34019714"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34019714"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Chuanying Zhu, Keke Li, Mawei Jiang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "RBM5-AS1 promotes radioresistance in medulloblastoma through stabilization of SIRT6 protein."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Acta Neuropathol Commun (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/s40478-021-01218-2"}], "href": "https://doi.org/10.1186/s40478-021-01218-2"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34225779"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34225779"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Xinping Li, Jingyan Yang, Ruiqi Ni, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Hypoxia-induced lncRNA RBM5-AS1 promotes tumorigenesis via activating Wnt/β-catenin signaling in breast cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Death Dis (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41419-022-04536-y"}], "href": "https://doi.org/10.1038/s41419-022-04536-y"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "35110544"}], "href": "https://pubmed.ncbi.nlm.nih.gov/35110544"}]}]}]}
|
| Synonyms | LUST |
| NCBI Gene ID | 100775107 |
| API | |
| Download Associations | |
| Predicted Functions |
![]() |
| Co-expressed Genes |
![]() |
| Expression in Tissues and Cell Lines |
![]() |
RBM5-AS1 has 378 functional associations with biological entities spanning 3 categories (molecular profile, cell line, cell type or tissue, gene, protein or microRNA) extracted from 8 datasets.
Click the + buttons to view associations for RBM5-AS1 from the datasets below.
If available, associations are ranked by standardized value
| Dataset | Summary | |
|---|---|---|
| CCLE Cell Line Gene CNV Profiles | cell lines with high or low copy number of RBM5-AS1 gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset. | |
| ENCODE Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at RBM5-AS1 gene from the ENCODE Histone Modification Site Profiles dataset. | |
| ENCODE Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of RBM5-AS1 gene from the ENCODE Transcription Factor Binding Site Profiles dataset. | |
| ENCODE Transcription Factor Targets | transcription factors binding the promoter of RBM5-AS1 gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset. | |
| GTEx Tissue-Specific Aging Signatures | tissue samples with high or low expression of RBM5-AS1 gene relative to other tissue samples from the GTEx Tissue-Specific Aging Signatures dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles | cell lines with high or low copy number of RBM5-AS1 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles | cell lines with high or low expression of RBM5-AS1 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles dataset. | |
| Roadmap Epigenomics Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at RBM5-AS1 gene from the Roadmap Epigenomics Histone Modification Site Profiles dataset. | |